Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

AGI-134 (Agalimmune)

	Next higher product group	cancer immunotherapy (immuno-oncology, I-O)
	Status	2017-03-23 development pc existent
	Organisation	Agalimmune Ltd.
	Group	BioLineRx (Group)
	Organisation 2	Kode Biotech Ltd.

Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for cancer immunotherapy (immuno-oncology, I-O)

[1] Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA....
[2] Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim....
[3] Neobe Therapeutics Ltd.. (2/29/24). "Press Release: Neobe Therapeutics Raises over $2m for Synthetic Biology Enabled Tumour Microenvironment Remodelling"....
[4] Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna....
[5] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
[6] BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz....
[7] Merck & Co., Inc.. (1/8/24). "Press Release: Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline". Rahway, NJ & South San Francisco, CA....
[8] Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford....
[9] Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim....
[10] IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]